Motor response complications in advanced Parkinson's disease.
Chase
T N
TN
Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20892.
Juncos
J L
JL
Fabbrini
G
G
Mouradian
M M
MM
D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced / Q000209:etiology*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
D007980:Levodopa